Cite

HARVARD Citation

    Gatto, M. et al. (n.d.). SAT0248 Baseline clasi-damage is a major predictor of skin response to belimumab in a multicentric cohort of sle patients. Annals of the rheumatic diseases. p. 867. [Online]. 
  
Back to record